Macroaxis is not in business of monitoring CVS Health headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with CVS Health Corporation brand which may create opportunities for some arbitrage if properly timed. With CVS Health hype-based prediction module you can estimate the value of CVS Health Corporation from the prospective of CVS Health response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on CVS Health over a specific investment horizon. Check also CVS Health Basic Forecasting Models to cross-verify your projections.
On 21 of June CVS Health Corporation is traded for 71.29. This company has historical hype elasticity of 0.37 and average elasticity to hype of competition of -0.01. CVS Health Corporation is estimated to increase in value after the next headline with price going to jump to 72.16. The average volatility of media hype impact on the company stock price is about 240.48%. The price escalation on the next news is estimated to be 0.52% where as daily expected return is currently at 0.44%. The volatility of related hype on CVS Health is about 6312.5% with expected price after next announcement by competition of 71.28. The company reported last year revenue of 185.94 B. Total Income to common stockholders was 6.65 B with profit before taxes, overhead, and interest of 28.55 B. Considering 30-days investment horizon, the next estimated press release will be in about 6 days. Check also CVS Health Basic Forecasting Models to cross-verify your projections.